Delivery Order SPE2DB20D2104-SPE2DB23FU21U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,332.06 firm fixed price delivery order is for the medication Gemtesa 75 mg tablet, with a completion date of March 20, 2024. Amerisourcebergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,707.91 Firm Fixed Price Delivery Order contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through December 11, 2024 and was awarded on December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,367.17 firm fixed-price delivery order is for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,846.91 Firm Fixed Price Delivery Order contract is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,265.36 Firm Fixed Price delivery order is for the supply of 4564361882 ! GEMTESA 75 MG TABLET 90S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides pharmaceutical products and medical supplies to the U.S. federal government. The award, valued at $1,623.94, is a delivery order issued under an existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999 through December 2025. The contract is for the supply of GEMTESA 75 MG TABLET 30S, a prescription medication, with a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $8,984.98 firm fixed-price delivery order contract is for the supply of the drug GEMTESA 75 MG TABLET 90S. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,781.80, is for the delivery of the pharmaceutical product GEMTESA 75 MG TABLET 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 10, 2024. This award is not associated with any set-aside program. Amerisourcebergen is a major supplier of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,330.94 for the pharmaceutical product Gemtesa 75 mg tablet 30s. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,083.10 contract is for the delivery of the prescription drug Gemtesa 75 mg tablets. It has a firm fixed price and an ultimate completion date of December 22, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU21UDelivery Order
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,203.98 firm fixed-price delivery order is for the supply of 4561390786 Gemtesa 75 mg tablets, with a completion date of July 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/30/23 |